Ligand profile
ZINC4097095
Virtual-screening candidate from ZINC.
Bound to: VK055_0887 — beta-galactosidase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC4097095- UniProt (similar protein)
P00722- Tanimoto
- 0.515
- Target protein
- VK055_0887
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 136.7
- −1 ≤ LogP ≤ 5 -2.08
- MW ≤ 500 Da 244.1
- LogP ≤ 5 -2.08
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 136.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=P(O)(O)OC[C@H]1O[C@H](O)C[C@@H](O)[C@@H]1OO=P(O)(O)OC[C@H]1O[C@H](O)C[C@@H](O)[C@@H]1O
InChI=1S/C6H13O8P/c7-3-1-5(8)14-4(6(3)9)2-13-15(10,11)12/h3-9H,1-2H2,(H2,10,11,12)/t3-,4-,5+,6+/m1/s1InChI=1S/C6H13O8P/c7-3-1-5(8)14-4(6(3)9)2-13-15(10,11)12/h3-9H,1-2H2,(H2,10,11,12)/t3-,4-,5+,6+/m1/s1
UQJFZAAGZAYVKZ-ZXXMMSQZSA-NUQJFZAAGZAYVKZ-ZXXMMSQZSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 2DG
- Homolog
- P00722
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC4097095 →
- ZINC ZINC20 ZINC4097095 →
- UniProt UniProt P00722 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC4097095”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0887.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).